Charles William Stark
SVP, Clinical Development, Emmaus Life Sciences, Inc.
Companies
- Emmaus Life Sciences, Inc.SVP, Clinical Development Dec 28, 2021 to Feb 5, 20241
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Emmaus Life Sciences, Inc. EMMA14,702 shares2$859 at $0.06Dec 28, 2021
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2